Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis Anne Claire HenryThijs J. Schoutenfor the Dutch Pancreatic Cancer Group Pancreatic Tumors Open access 02 June 2022 Pages: 6031 - 6042
ASO Author Reflections: Nationwide Reflection of Clinical Outcomes in Elderly Patients after Resection of Pancreatic Cancer Anne Claire HenryThijs J. SchoutenHjalmar C. van Santvoort ASO Author Reflections Open access 26 May 2022 Pages: 6043 - 6044
ASO Visual Abstract: Short- and Long-Term Outcomes of Pancreatic Cancer Resection for Elderly Patients: A Nationwide Analysis A. C. HenryT. J. Schoutenthe Dutch Pancreatic Cancer Group ASO Visual Abstract 11 May 2022 Pages: 6045 - 6046
Correction to: ASO Visual Abstract: Optimizing the Indications for Conversion Surgery Based on an Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study Yuta UshidaYosuke InoueYu Takahashi Correction 18 April 2022 Pages: 6047 - 6047
Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes Christoph FrauneEike BurandtStefan Steurer Correction Open access 21 April 2022 Pages: 6048 - 6048
Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Rogini BalachandranLouise Zinck MogensenLene Hjerrild Iversen Peritoneal Surface Malignancy 25 February 2022 Pages: 6049 - 6083
ASO Author Reflections: Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy—A Scoping Review Rogini Balachandran ASO Author Reflections 21 February 2022 Pages: 6084 - 6085
ASO Visual Abstract: Organ-specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy—A Scoping Review Rogini BalachandranLouise Zinck MogensenLene Hjerrild Iversen ASO Visual Abstract 15 February 2022 Pages: 6086 - 6086